Home workouts could boost heart recovery: new trial
NCT ID NCT07130045
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This trial tests a hybrid exercise program (HyBEST) for people with coronary artery disease. It combines supervised sessions at a center with home workouts using a wearable tracker. The goal is to see if this approach improves exercise capacity, body composition, and quality of life better than standard care. 84 participants will be randomly assigned to either the HyBEST program or usual cardiac rehab.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Hybrid endurance and strength training (HyBEST) exercise program
What this could lead to
If successful, this hybrid exercise program could offer a convenient, effective way for heart patients to improve fitness and quality of life at home.
What could go wrong
This is a small, early-stage trial with only 84 participants. The home-based component relies on patient adherence, and results may not apply to all heart patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE (CAD) (E.G., ANGINA, MYOCARDIAL INFARCTION, AND ATHEROSCLEROTIC HEART DISEASE (ASHD)) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Universiti Malaya Medical Center
Kuala Lumpur, Lembah Pantai, 59100, Malaysia
Contact Phone: •••-•••-•••• Email: •••••@•••••